MedTrace Logo

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

NCT05925036 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-07

No results posted yet for this study

Summary

The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.

Conditions

Interventions

DRUG

Mesenchymal stem cells

Autologous bone marrow derived MSCs

OTHER

Placebo

Controls

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Hongjun N Wang, PhD · Ralph H. Johnson VA Medical Center, Charleston, SC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-12-31
Completion
2027-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05925036 on ClinicalTrials.gov